NFKB1 and COVID-19: Elevated levels of TLRs such as TLR2 and Toll-Like Receptor 4 (TLR4), alongside increased expression of the Nuclear Factor Kappa B (NF-κB) transcription factor, were observed more so in severe compared to moderate COVID-19 patients (Fig 3C).